TOWER HOUSE PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: N81057 | RUNCORN, WA7 1AB
Showing results 451-500 of 649
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Brinzolamide/brimonidine | 32 | 160 | £281 | -6.7% ▼ |
| Tars | 32 | 8,150 | £509 | +281.8% ▲ |
| 32 | 621 | £315 | -18.8% ▼ | |
| Zinc oxide | 31 | 878 | £108 | +49.8% ▲ |
| Erythromycin ethylsuccinate | 31 | 9,148 | £1.1K | +32.8% ▲ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 31 | 2,950 | £137 | +106.3% ▲ |
| Salicylic acid | 31 | 272 | £114 | +145.2% ▲ |
| Balsalazide sodium | 30 | 2,688 | £601 | +101.4% ▲ |
| Acarbose | 30 | 2,290 | £842 | +157.0% ▲ |
| Adapalene | 30 | 1,440 | £500 | +37.1% ▲ |
| 30 | 515 | £746 | +239.0% ▲ | |
| 30 | 23.0K | £300 | -67.1% ▼ | |
| 30 | 300 | £772 | +155.1% ▲ | |
| Perindopril arginine | 29 | 1,050 | £289 | +145.2% ▲ |
| Phenobarbital | 29 | 1,090 | £86 | -5.7% ▼ |
| Methenamine hippurate | 29 | 2,148 | £597 | -68.1% ▼ |
| Dulaglutide | 29 | 116 | £2.1K | -74.7% ▼ |
| Acetazolamide | 29 | 1,678 | £65 | +33.8% ▲ |
| Simple | 28 | 10.3K | £75 | +143.9% ▲ |
| Betamethasone sodium phosphate | 28 | 380 | £84 | +8.1% ▲ |
| Clindamycin phosphate | 28 | 1,230 | £198 | +70.2% ▲ |
| 28 | 629 | £91 | -6.3% ▼ | |
| 28 | 840 | £818 | +62.6% ▲ | |
| 28 | 12.3K | £695 | -72.4% ▼ | |
| Rasagiline mesilate | 27 | 756 | £513 | -27.3% ▼ |
| Mycophenolate mofetil | 27 | 2,804 | £2.6K | -33.3% ▼ |
| Pdr 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 27 | 980 | £1.1K | +310.3% ▲ |
| Ready to serve 4.5 - 5 kcal/ml energy (fat) liquid (0913142) | 27 | 53.0K | £1.7K | +140.8% ▲ |
| Fluocinolone acetonide | 27 | 1,080 | £143 | +147.9% ▲ |
| Ivermectin | 27 | 1,275 | £740 | +27.0% ▲ |
| Benzalkonium chloride | 27 | 7,750 | £171 | +135.4% ▲ |
| Mupirocin | 27 | 450 | £158 | +190.8% ▲ |
| Nizatidine | 26 | 888 | £922 | -24.4% ▼ |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 26 | 952 | £127 | -25.3% ▼ |
| Reboxetine | 26 | 1,820 | £548 | +68.8% ▲ |
| Hyoscine hydrobromide | 26 | 3,126 | £497 | -23.9% ▼ |
| Other compound vitamin/mineral formulation preparations | 26 | 2,004 | £291 | -18.9% ▼ |
| Tube feed 1.5 kcal/ml with fibre (0914021) | 26 | 398.0K | £10.7K | +126.9% ▲ |
| Febuxostat | 26 | 728 | £71 | -30.4% ▼ |
| Gamolenic acid | 26 | 3,396 | £816 | +151.8% ▲ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 26 | 966 | £114 | +199.7% ▲ |
| 26 | 18.3K | £1.6K | -31.8% ▼ | |
| Glyceryl trinitrate | 25 | 900 | £1.1K | +88.2% ▲ |
| Lurasidone | 25 | 436 | £1.2K | +0.2% vs avg |
| Tetrabenazine | 25 | 700 | £744 | +57.7% ▲ |
| Cefradine | 25 | 976 | £704 | +164.1% ▲ |
| Itraconazole | 25 | 947 | £433 | +86.4% ▲ |
| Mercaptopurine | 25 | 664 | £321 | +61.5% ▲ |
| Tacrolimus | 25 | 1,400 | £1.9K | -6.5% ▼ |
| Menthol | 25 | 9,700 | £350 | -11.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.